SUBSCRIBE
SUBSCRIBE
News   Policy

US Seeks More Information on Novartis AG (JOBS) Lung Drug

October 19, 2009 | 
1 min read
Bookmark and Share

Reuters -- U.S. regulators have asked for more information on dosing proposed for a drug from Novartis AG for "smoker's lung", or chronic obstructive pulmonary disease, the Swiss group said on Monday.
Regulatory
Novartis
MORE ON THIS TOPIC
Business people and concepts vector art exit
Government
Prasad ally Szarama exits CBER after 3 weeks as FDA cleanout continues
May 18, 2026
 · 
1 min read
 · 
Tristan Manalac
Illustration of young woman standing in front of exit door
FDA
Interim CDER head Høeg is out days after Makary: report
May 15, 2026
 · 
2 min read
 · 
Gabrielle Masson
Illustration showing a downward graph trend
Regulatory
Future of Aardvark’s Prader-Willi drug in doubt as FDA slaps full hold on program
May 15, 2026
 · 
2 min read
 · 
Tristan Manalac
Businessperson group is walking towards career success or a vacant promotion competition. isometric vector illustration.
FDA
Biotech leaders pitch Pazdur as next FDA chief
May 14, 2026
 · 
2 min read
 · 
Annalee Armstrong